It has been a rotten year for Apellis Pharmaceuticals stock, but better times could be ahead.…
It has been a rotten year for Apellis Pharmaceuticals stock, but better times could be ahead.…
WALTHAM, Mass., Oct. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi® today announced that…
· Statistically significant 68% (p…
SAN DIEGO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations…
Die Apellis Pharmaceuticals Aktie verzeichnete am 12. Oktober 2024 einen leichten Anstieg von 0,08% auf 24,64 EUR. Trotz dieses minimalen…
…
WALTHAM, Mass., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the Committee…
Apellis Pharmaceuticals shares surge after study results…
· Met the primary endpoint, achieving statistically significant 68% (p…
…
· Rapid reduction in disease activity seen at 12 weeks sustained at one year
· 55% of patients showed…
WALTHAM, Mass. and STOCKHOLM, Sweden, May 24, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi® (STO:SOBI)…
SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations…
…
Earnings call: Apellis Pharmaceuticals Q1 2024 financials show growth…
WALTHAM, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will…
Apellis Pharmaceuticals stock falls following Mizuho comments, price target cut…
WALTHAM, Mass., April 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the European…
WALTHAM, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will…
Apellis Pharmaceuticals director sells over $1 million in company stock…
Apellis Pharmaceuticals officer sells $564k in company stock…
Apellis Pharmaceuticals VP sells over $10k in company stock…
SAN DIEGO, March 05, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations…
UBS raises Apellis Pharmaceuticals shares target on strong outlook…
…
…
…
…
Apellis Pharmaceuticals upgraded to buy by Jefferies…
SAN DIEGO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) …
WALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will…
WALTHAM, Mass., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will…
SAN DIEGO, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) …
Apellis Pharmaceuticals Inc (NASDAQ:APLS) shares fell more than 22% after it said it expects European regulators to reject its therapeutic…
© Reuters. Apellis Pharmaceuticals (APLS) stock just tumbled. Here’s why Apellis Pharma (APLS) stock experienced a sharp pre-market decline following…
Apellis Pharmaceuticals Inc.’s stock APLS tumbled 14% early Thursday, after the company said it’s been informed of a negative trend…
…
Apellis Pharmaceuticals stock just tumbled. Heres why…
WALTHAM, Mass., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi today presented post…
SAN DIEGO, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)…
…
WALTHAM, Mass., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced that the company will…
Apellis Pharmaceuticals tumbles as Citron Research says legal action seems imminent…
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
…
…
…
SAN DIEGO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) …
…